 Kenneth Tyler
Concepts (771)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Reoviridae Infections | 40 | 2019 | 52 | 8.190 |
Why?
| | West Nile Fever | 22 | 2023 | 50 | 7.330 |
Why?
| | Encephalitis, Viral | 23 | 2021 | 39 | 6.060 |
Why?
| | West Nile virus | 17 | 2023 | 38 | 5.970 |
Why?
| | Enterovirus D, Human | 13 | 2023 | 72 | 5.640 |
Why?
| | Enterovirus Infections | 13 | 2023 | 160 | 4.940 |
Why?
| | Central Nervous System Viral Diseases | 17 | 2023 | 63 | 4.830 |
Why?
| | Reoviridae | 26 | 2019 | 35 | 4.470 |
Why?
| | Myelitis | 20 | 2022 | 88 | 4.470 |
Why?
| | Leukoencephalopathy, Progressive Multifocal | 15 | 2019 | 38 | 4.230 |
Why?
| | Mammalian orthoreovirus 3 | 30 | 2019 | 34 | 3.850 |
Why?
| | Apoptosis | 44 | 2021 | 2369 | 3.680 |
Why?
| | Nervous System Diseases | 15 | 2020 | 252 | 3.670 |
Why?
| | Brain | 37 | 2023 | 2369 | 3.440 |
Why?
| | Antiviral Agents | 19 | 2023 | 646 | 3.030 |
Why?
| | Neuromuscular Diseases | 9 | 2022 | 89 | 2.280 |
Why?
| | Central Nervous System Infections | 7 | 2022 | 36 | 2.230 |
Why?
| | Neurology | 12 | 2017 | 84 | 2.210 |
Why?
| | Zika Virus Infection | 5 | 2017 | 85 | 2.140 |
Why?
| | Neurons | 21 | 2022 | 1280 | 1.870 |
Why?
| | Encephalitis | 8 | 2022 | 127 | 1.860 |
Why?
| | Acyclovir | 9 | 2020 | 100 | 1.840 |
Why?
| | Paralysis | 9 | 2023 | 66 | 1.790 |
Why?
| | Encephalitis, Herpes Simplex | 8 | 2020 | 19 | 1.740 |
Why?
| | Mice | 74 | 2023 | 14916 | 1.710 |
Why?
| | Host-Pathogen Interactions | 5 | 2021 | 295 | 1.700 |
Why?
| | Animals | 107 | 2023 | 31761 | 1.660 |
Why?
| | Microglia | 7 | 2023 | 202 | 1.620 |
Why?
| | Multiple Sclerosis | 5 | 2022 | 380 | 1.460 |
Why?
| | Simplexvirus | 13 | 2020 | 80 | 1.440 |
Why?
| | Meningoencephalitis | 6 | 2021 | 24 | 1.430 |
Why?
| | Herpes Simplex | 7 | 2021 | 87 | 1.330 |
Why?
| | Zika Virus | 4 | 2017 | 61 | 1.320 |
Why?
| | Polymerase Chain Reaction | 17 | 2018 | 994 | 1.320 |
Why?
| | Spinal Cord | 8 | 2021 | 347 | 1.270 |
Why?
| | Communicable Diseases, Emerging | 4 | 2016 | 28 | 1.270 |
Why?
| | Central Nervous System Diseases | 5 | 2023 | 61 | 1.250 |
Why?
| | Humans | 157 | 2023 | 114716 | 1.230 |
Why?
| | Cell Death | 4 | 2022 | 322 | 1.220 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2022 | 440 | 1.170 |
Why?
| | Herpesviridae Infections | 6 | 2013 | 138 | 1.170 |
Why?
| | Viral Load | 6 | 2023 | 405 | 1.140 |
Why?
| | Meningitis, Viral | 8 | 2020 | 21 | 1.110 |
Why?
| | Virus Replication | 19 | 2021 | 395 | 1.070 |
Why?
| | Central Nervous System | 9 | 2017 | 237 | 1.060 |
Why?
| | Interferon-beta | 4 | 2019 | 79 | 1.040 |
Why?
| | Disease Outbreaks | 6 | 2022 | 309 | 1.030 |
Why?
| | Disease Models, Animal | 13 | 2023 | 3542 | 1.020 |
Why?
| | JC Virus | 8 | 2015 | 23 | 1.020 |
Why?
| | Meningitis | 4 | 2023 | 74 | 1.000 |
Why?
| | Arbovirus Infections | 3 | 2019 | 17 | 0.990 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 340 | 0.980 |
Why?
| | Coronavirus Infections | 2 | 2020 | 332 | 0.980 |
Why?
| | Epstein-Barr Virus Infections | 2 | 2022 | 72 | 0.970 |
Why?
| | Motor Neurons | 3 | 2019 | 212 | 0.940 |
Why?
| | Cytokines | 9 | 2022 | 1843 | 0.940 |
Why?
| | Monkeypox virus | 3 | 2023 | 12 | 0.930 |
Why?
| | Signal Transduction | 17 | 2019 | 4521 | 0.920 |
Why?
| | Herpesvirus 1, Human | 3 | 2021 | 76 | 0.920 |
Why?
| | Creutzfeldt-Jakob Syndrome | 5 | 2007 | 14 | 0.900 |
Why?
| | Orthoreovirus, Mammalian | 4 | 2011 | 5 | 0.900 |
Why?
| | Virion | 3 | 2022 | 73 | 0.890 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2023 | 140 | 0.880 |
Why?
| | Caspase 3 | 7 | 2023 | 236 | 0.870 |
Why?
| | Guillain-Barre Syndrome | 3 | 2020 | 21 | 0.860 |
Why?
| | Dog Diseases | 2 | 2021 | 41 | 0.860 |
Why?
| | Sexual and Gender Minorities | 2 | 2022 | 137 | 0.860 |
Why?
| | Capsid Proteins | 8 | 2004 | 69 | 0.840 |
Why?
| | Natalizumab | 4 | 2019 | 46 | 0.840 |
Why?
| | Minocycline | 2 | 2017 | 26 | 0.830 |
Why?
| | Astrocytes | 5 | 2019 | 162 | 0.810 |
Why?
| | Virus Diseases | 7 | 2009 | 195 | 0.800 |
Why?
| | Spine | 2 | 2017 | 135 | 0.800 |
Why?
| | Immunity, Innate | 5 | 2021 | 723 | 0.790 |
Why?
| | Fluoxetine | 3 | 2018 | 46 | 0.790 |
Why?
| | Meningitis, Bacterial | 4 | 2010 | 48 | 0.760 |
Why?
| | Caspase Inhibitors | 5 | 2011 | 78 | 0.740 |
Why?
| | Exosomes | 1 | 2022 | 91 | 0.730 |
Why?
| | Critical Care | 2 | 2017 | 473 | 0.720 |
Why?
| | Betacoronavirus | 2 | 2020 | 252 | 0.710 |
Why?
| | Encephalitis, California | 2 | 2019 | 11 | 0.690 |
Why?
| | Encephalitis, Tick-Borne | 2 | 2019 | 8 | 0.690 |
Why?
| | Hashimoto Disease | 1 | 2019 | 9 | 0.680 |
Why?
| | Immunosuppressive Agents | 3 | 2015 | 647 | 0.670 |
Why?
| | N-Acetylneuraminic Acid | 1 | 2019 | 8 | 0.670 |
Why?
| | Axonal Transport | 1 | 2019 | 21 | 0.670 |
Why?
| | Cell Line | 18 | 2022 | 2639 | 0.670 |
Why?
| | Zoonoses | 2 | 2009 | 21 | 0.660 |
Why?
| | Periodicals as Topic | 1 | 2021 | 181 | 0.660 |
Why?
| | Immune System | 2 | 2020 | 173 | 0.650 |
Why?
| | Encephalitis, Japanese | 1 | 2018 | 2 | 0.630 |
Why?
| | Orthoreovirus | 5 | 1998 | 6 | 0.630 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 5 | 2009 | 144 | 0.610 |
Why?
| | Prion Diseases | 3 | 2008 | 10 | 0.580 |
Why?
| | Herpes Zoster | 2 | 2015 | 331 | 0.570 |
Why?
| | Neurosyphilis | 2 | 2013 | 3 | 0.570 |
Why?
| | Plasma Exchange | 1 | 2017 | 12 | 0.570 |
Why?
| | Enzyme Inhibitors | 3 | 2011 | 751 | 0.570 |
Why?
| | Hepatitis E | 1 | 2017 | 2 | 0.560 |
Why?
| | Hepatitis E virus | 1 | 2017 | 2 | 0.560 |
Why?
| | NF-kappa B | 7 | 2010 | 636 | 0.560 |
Why?
| | Antibodies, Monoclonal | 11 | 2009 | 1270 | 0.560 |
Why?
| | Herpesvirus 3, Human | 3 | 2015 | 378 | 0.550 |
Why?
| | Virology | 1 | 2016 | 19 | 0.550 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 1 | 2016 | 13 | 0.550 |
Why?
| | Macrophage Activation | 1 | 2017 | 164 | 0.550 |
Why?
| | Viruses | 6 | 2009 | 94 | 0.540 |
Why?
| | Myocarditis | 5 | 2009 | 93 | 0.540 |
Why?
| | Alzheimer Disease | 1 | 2021 | 436 | 0.540 |
Why?
| | Prions | 3 | 2008 | 33 | 0.530 |
Why?
| | Caspases | 9 | 2013 | 245 | 0.520 |
Why?
| | Immunocompromised Host | 5 | 2009 | 195 | 0.510 |
Why?
| | Gene Expression Regulation | 6 | 2010 | 2321 | 0.500 |
Why?
| | History, 20th Century | 10 | 2016 | 265 | 0.500 |
Why?
| | Thrombocytopenia | 1 | 2017 | 177 | 0.500 |
Why?
| | Toll-Like Receptor 3 | 2 | 2014 | 26 | 0.500 |
Why?
| | Chikungunya Fever | 1 | 2016 | 61 | 0.490 |
Why?
| | Cerebrospinal Fluid | 7 | 2005 | 90 | 0.490 |
Why?
| | Anti-Inflammatory Agents | 3 | 2017 | 450 | 0.490 |
Why?
| | Antibodies, Viral | 7 | 2019 | 521 | 0.490 |
Why?
| | Propylene Glycols | 1 | 2015 | 25 | 0.480 |
Why?
| | Valine | 1 | 2015 | 72 | 0.480 |
Why?
| | Glial Fibrillary Acidic Protein | 5 | 2021 | 79 | 0.480 |
Why?
| | Medication Reconciliation | 1 | 2015 | 25 | 0.480 |
Why?
| | Sphingosine | 1 | 2015 | 33 | 0.480 |
Why?
| | Calpain | 4 | 2008 | 53 | 0.470 |
Why?
| | Encephalitis Viruses, Japanese | 1 | 2014 | 1 | 0.470 |
Why?
| | Leukoencephalitis, Acute Hemorrhagic | 2 | 2020 | 3 | 0.470 |
Why?
| | Nervous System | 2 | 2007 | 63 | 0.470 |
Why?
| | Drug Discovery | 1 | 2015 | 124 | 0.460 |
Why?
| | Encephalitis, St. Louis | 1 | 2014 | 2 | 0.460 |
Why?
| | Encephalitis Virus, St. Louis | 1 | 2014 | 3 | 0.460 |
Why?
| | Capsid | 5 | 1997 | 75 | 0.460 |
Why?
| | PrPSc Proteins | 2 | 2004 | 5 | 0.460 |
Why?
| | Receptors, Death Domain | 1 | 2013 | 3 | 0.460 |
Why?
| | Viral Proteins | 8 | 2000 | 281 | 0.450 |
Why?
| | Interferon Type I | 2 | 2013 | 128 | 0.450 |
Why?
| | Male | 48 | 2023 | 55558 | 0.450 |
Why?
| | Peripheral Nervous System | 1 | 2013 | 17 | 0.450 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 5 | 2007 | 40 | 0.440 |
Why?
| | Heart | 3 | 2011 | 609 | 0.440 |
Why?
| | Penicillins | 1 | 2013 | 52 | 0.440 |
Why?
| | Neuroglia | 3 | 2012 | 150 | 0.430 |
Why?
| | Epidemics | 1 | 2014 | 69 | 0.430 |
Why?
| | Carrier Proteins | 6 | 2013 | 696 | 0.430 |
Why?
| | Viral Nonstructural Proteins | 2 | 2005 | 54 | 0.420 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 447 | 0.420 |
Why?
| | Phagocytosis | 1 | 2014 | 350 | 0.410 |
Why?
| | Acute Disease | 6 | 2018 | 912 | 0.410 |
Why?
| | Receptor, Interferon alpha-beta | 2 | 2012 | 23 | 0.410 |
Why?
| | Enterovirus | 3 | 2023 | 72 | 0.400 |
Why?
| | DNA, Viral | 8 | 2003 | 350 | 0.400 |
Why?
| | STAT1 Transcription Factor | 3 | 2012 | 65 | 0.390 |
Why?
| | United States | 13 | 2023 | 12176 | 0.390 |
Why?
| | Animals, Newborn | 9 | 2021 | 777 | 0.390 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 2 | 2011 | 82 | 0.390 |
Why?
| | Brain Diseases | 3 | 2020 | 124 | 0.380 |
Why?
| | Gene Expression Profiling | 3 | 2014 | 1521 | 0.380 |
Why?
| | Female | 41 | 2021 | 59486 | 0.370 |
Why?
| | bcl-2-Associated X Protein | 1 | 2011 | 45 | 0.370 |
Why?
| | Caspase 8 | 5 | 2013 | 43 | 0.360 |
Why?
| | Immunoglobulins, Intravenous | 3 | 2019 | 122 | 0.360 |
Why?
| | Macrophages | 1 | 2017 | 1261 | 0.360 |
Why?
| | fas Receptor | 2 | 2009 | 92 | 0.360 |
Why?
| | Chemokines | 2 | 2022 | 213 | 0.360 |
Why?
| | History, 19th Century | 10 | 2010 | 54 | 0.360 |
Why?
| | Genes, Viral | 9 | 1998 | 89 | 0.360 |
Why?
| | Virus Internalization | 2 | 2022 | 40 | 0.360 |
Why?
| | Cysteine Proteinase Inhibitors | 3 | 2001 | 45 | 0.350 |
Why?
| | Tumor Necrosis Factor-alpha | 4 | 2003 | 1134 | 0.350 |
Why?
| | Neuroprotective Agents | 1 | 2011 | 105 | 0.340 |
Why?
| | Up-Regulation | 5 | 2016 | 812 | 0.340 |
Why?
| | Antibodies, Neutralizing | 3 | 2022 | 221 | 0.340 |
Why?
| | CASP8 and FADD-Like Apoptosis Regulating Protein | 2 | 2007 | 20 | 0.340 |
Why?
| | Flavivirus Infections | 2 | 2019 | 9 | 0.340 |
Why?
| | Immunomodulation | 1 | 2010 | 84 | 0.340 |
Why?
| | Cerebellum | 3 | 2012 | 200 | 0.340 |
Why?
| | Membrane Glycoproteins | 5 | 2004 | 429 | 0.330 |
Why?
| | Enzyme Activation | 3 | 2010 | 787 | 0.330 |
Why?
| | Cell Cycle | 2 | 2002 | 543 | 0.320 |
Why?
| | Cells, Cultured | 12 | 2013 | 3890 | 0.320 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 2 | 2009 | 69 | 0.310 |
Why?
| | HeLa Cells | 7 | 2018 | 562 | 0.310 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2009 | 132 | 0.310 |
Why?
| | Discitis | 1 | 2008 | 2 | 0.300 |
Why?
| | Motor Neuron Disease | 1 | 2008 | 16 | 0.300 |
Why?
| | Spinal Cord Diseases | 1 | 2008 | 38 | 0.300 |
Why?
| | Bone Diseases, Infectious | 1 | 2008 | 8 | 0.300 |
Why?
| | Bell Palsy | 1 | 2007 | 6 | 0.300 |
Why?
| | Caspase 9 | 4 | 2013 | 48 | 0.290 |
Why?
| | Back Pain | 1 | 2008 | 44 | 0.290 |
Why?
| | Janus Kinases | 1 | 2007 | 12 | 0.290 |
Why?
| | Prednisolone | 1 | 2007 | 75 | 0.290 |
Why?
| | Rituximab | 3 | 2021 | 150 | 0.290 |
Why?
| | Apoptosis Regulatory Proteins | 7 | 2005 | 171 | 0.280 |
Why?
| | Cytomegalovirus | 2 | 2004 | 144 | 0.280 |
Why?
| | Wasting Disease, Chronic | 1 | 2007 | 18 | 0.280 |
Why?
| | Kuru | 2 | 2004 | 2 | 0.280 |
Why?
| | Adult | 26 | 2022 | 30543 | 0.280 |
Why?
| | Health Services Needs and Demand | 1 | 2008 | 244 | 0.270 |
Why?
| | Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2007 | 56 | 0.270 |
Why?
| | Transforming Growth Factor beta | 1 | 2009 | 449 | 0.270 |
Why?
| | Mitochondrial Proteins | 2 | 2005 | 219 | 0.260 |
Why?
| | Homosexuality, Male | 3 | 2022 | 170 | 0.260 |
Why?
| | Feces | 1 | 2008 | 374 | 0.260 |
Why?
| | Child, Preschool | 9 | 2022 | 9079 | 0.260 |
Why?
| | Magnetic Resonance Imaging | 10 | 2023 | 3031 | 0.260 |
Why?
| | Dogs | 4 | 2021 | 334 | 0.260 |
Why?
| | Mice, Knockout | 7 | 2012 | 2582 | 0.260 |
Why?
| | Cytochromes c | 2 | 2005 | 63 | 0.250 |
Why?
| | Integrin alpha4 | 1 | 2005 | 6 | 0.250 |
Why?
| | Child | 15 | 2022 | 18352 | 0.250 |
Why?
| | Viral Tropism | 2 | 2018 | 24 | 0.250 |
Why?
| | Encephalomyelitis, Eastern Equine | 2 | 2019 | 6 | 0.250 |
Why?
| | Herpesvirus 4, Human | 2 | 2022 | 125 | 0.250 |
Why?
| | RNA, Viral | 5 | 2004 | 566 | 0.250 |
Why?
| | Health Surveys | 1 | 2007 | 443 | 0.250 |
Why?
| | Opportunistic Infections | 1 | 2005 | 43 | 0.250 |
Why?
| | Nitric Oxide Synthase | 1 | 2005 | 209 | 0.240 |
Why?
| | Scrapie | 1 | 2004 | 2 | 0.240 |
Why?
| | Intracellular Signaling Peptides and Proteins | 4 | 2013 | 386 | 0.240 |
Why?
| | Acquired Immunodeficiency Syndrome | 2 | 2003 | 218 | 0.240 |
Why?
| | History, 21st Century | 3 | 2016 | 160 | 0.240 |
Why?
| | Immunologic Factors | 2 | 2021 | 220 | 0.230 |
Why?
| | Recombinant Proteins | 3 | 2023 | 1233 | 0.230 |
Why?
| | Oligodendroglia | 2 | 2003 | 148 | 0.230 |
Why?
| | Cell Nucleus | 2 | 2004 | 554 | 0.230 |
Why?
| | Mitochondria | 5 | 2016 | 751 | 0.230 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2004 | 110 | 0.230 |
Why?
| | Blotting, Western | 5 | 2010 | 1151 | 0.230 |
Why?
| | Adjuvants, Immunologic | 1 | 2005 | 206 | 0.230 |
Why?
| | Middle Aged | 23 | 2019 | 26746 | 0.230 |
Why?
| | Treatment Outcome | 8 | 2019 | 9089 | 0.220 |
Why?
| | Hand, Foot and Mouth Disease | 1 | 2023 | 3 | 0.220 |
Why?
| | Medical Tourism | 1 | 2023 | 9 | 0.220 |
Why?
| | Age of Onset | 1 | 2005 | 447 | 0.220 |
Why?
| | Encephalomyelitis, Acute Disseminated | 2 | 2020 | 13 | 0.220 |
Why?
| | Arthropod Vectors | 2 | 2016 | 7 | 0.220 |
Why?
| | Roseolovirus Infections | 1 | 2003 | 7 | 0.220 |
Why?
| | Neutralization Tests | 4 | 2017 | 63 | 0.220 |
Why?
| | Glucocorticoids | 1 | 2007 | 532 | 0.220 |
Why?
| | Nitric Oxide Synthase Type II | 2 | 2017 | 157 | 0.220 |
Why?
| | Antigens, Viral | 4 | 2009 | 176 | 0.220 |
Why?
| | Herpesvirus 6, Human | 1 | 2003 | 13 | 0.220 |
Why?
| | Reassortant Viruses | 3 | 2005 | 7 | 0.220 |
Why?
| | Disease Progression | 7 | 2010 | 2384 | 0.210 |
Why?
| | Immunohistochemistry | 3 | 2017 | 1635 | 0.210 |
Why?
| | Immunization, Passive | 3 | 1993 | 73 | 0.210 |
Why?
| | Flavivirus | 2 | 2019 | 16 | 0.210 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 3 | 2009 | 10 | 0.210 |
Why?
| | Arthritis, Rheumatoid | 1 | 2011 | 1002 | 0.210 |
Why?
| | HIV Infections | 2 | 2013 | 2469 | 0.210 |
Why?
| | Encephalomyelitis | 1 | 2022 | 9 | 0.210 |
Why?
| | Antibodies, Monoclonal, Humanized | 4 | 2017 | 664 | 0.210 |
Why?
| | Olfactory Mucosa | 1 | 2003 | 60 | 0.210 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2003 | 80 | 0.210 |
Why?
| | Poliomyelitis | 1 | 2022 | 27 | 0.210 |
Why?
| | Organ Culture Techniques | 2 | 2014 | 141 | 0.210 |
Why?
| | Survival Analysis | 3 | 2018 | 1218 | 0.200 |
Why?
| | Virulence | 6 | 2005 | 227 | 0.200 |
Why?
| | Cytomegalovirus Infections | 1 | 2004 | 182 | 0.200 |
Why?
| | Anti-Bacterial Agents | 5 | 2022 | 1477 | 0.200 |
Why?
| | Densitometry | 1 | 2022 | 29 | 0.200 |
Why?
| | Ovarian Neoplasms | 1 | 2007 | 388 | 0.200 |
Why?
| | Sequence Analysis, DNA | 4 | 2017 | 728 | 0.200 |
Why?
| | Poliovirus | 1 | 2022 | 77 | 0.200 |
Why?
| | Pandemics | 2 | 2020 | 1319 | 0.200 |
Why?
| | Organ Transplantation | 1 | 2004 | 159 | 0.200 |
Why?
| | Exanthema | 1 | 2022 | 74 | 0.200 |
Why?
| | Peptides | 1 | 2007 | 848 | 0.200 |
Why?
| | DNA Repair | 1 | 2003 | 186 | 0.200 |
Why?
| | Mycobacterium abscessus | 1 | 2023 | 98 | 0.190 |
Why?
| | Stroke | 2 | 2020 | 1019 | 0.190 |
Why?
| | Nervous System Malformations | 1 | 2022 | 34 | 0.190 |
Why?
| | CDC2 Protein Kinase | 1 | 2001 | 25 | 0.190 |
Why?
| | Enterovirus A, Human | 1 | 2021 | 12 | 0.190 |
Why?
| | Interferons | 2 | 2014 | 151 | 0.190 |
Why?
| | Dipeptides | 1 | 2001 | 48 | 0.180 |
Why?
| | G2 Phase | 1 | 2000 | 31 | 0.180 |
Why?
| | Manuscripts, Medical as Topic | 1 | 2000 | 4 | 0.180 |
Why?
| | DNA-Directed DNA Polymerase | 2 | 1998 | 44 | 0.180 |
Why?
| | Herpes Zoster Ophthalmicus | 1 | 2020 | 5 | 0.180 |
Why?
| | Pigmentation Disorders | 1 | 2020 | 7 | 0.180 |
Why?
| | Anti-Infective Agents | 2 | 2022 | 225 | 0.180 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2020 | 30 | 0.180 |
Why?
| | Inflammation | 3 | 2020 | 2481 | 0.180 |
Why?
| | Encephalitis Virus, California | 2 | 2019 | 6 | 0.180 |
Why?
| | Sinus Thrombosis, Intracranial | 1 | 2020 | 21 | 0.180 |
Why?
| | Ophthalmoplegia | 1 | 1999 | 8 | 0.170 |
Why?
| | Immunoglobulin G | 3 | 2019 | 774 | 0.170 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2000 | 139 | 0.170 |
Why?
| | Facial Paralysis | 1 | 1999 | 17 | 0.170 |
Why?
| | Molecular Sequence Data | 4 | 2011 | 2791 | 0.170 |
Why?
| | Thrombophilia | 1 | 2020 | 66 | 0.170 |
Why?
| | Time Factors | 9 | 2008 | 6124 | 0.170 |
Why?
| | Central Nervous System Bacterial Infections | 1 | 1999 | 5 | 0.170 |
Why?
| | Craniofacial Abnormalities | 1 | 2020 | 59 | 0.170 |
Why?
| | Intracranial Hemorrhages | 1 | 2020 | 76 | 0.170 |
Why?
| | Bunyaviridae Infections | 1 | 2019 | 6 | 0.170 |
Why?
| | Olfaction Disorders | 1 | 2020 | 50 | 0.170 |
Why?
| | Pons | 1 | 1999 | 30 | 0.170 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2012 | 368 | 0.170 |
Why?
| | Nerve Degeneration | 2 | 2011 | 40 | 0.170 |
Why?
| | Genes, pol | 2 | 1998 | 7 | 0.170 |
Why?
| | Mitosis | 1 | 2000 | 164 | 0.170 |
Why?
| | Myelitis, Transverse | 1 | 2019 | 3 | 0.160 |
Why?
| | Gliosis | 1 | 2019 | 29 | 0.160 |
Why?
| | North America | 2 | 2019 | 257 | 0.160 |
Why?
| | Writing | 1 | 2000 | 83 | 0.160 |
Why?
| | Mental Disorders | 1 | 2007 | 889 | 0.160 |
Why?
| | Myelin-Oligodendrocyte Glycoprotein | 1 | 2019 | 44 | 0.160 |
Why?
| | MAP Kinase Kinase Kinase 1 | 3 | 2004 | 14 | 0.160 |
Why?
| | rho-Associated Kinases | 1 | 2019 | 80 | 0.160 |
Why?
| | Encephalitis Virus, Japanese | 1 | 2018 | 1 | 0.160 |
Why?
| | Blood-Brain Barrier | 1 | 2019 | 106 | 0.160 |
Why?
| | Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 12 | 0.160 |
Why?
| | Abnormalities, Multiple | 1 | 2020 | 177 | 0.160 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 333 | 0.160 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 3 | 2007 | 213 | 0.150 |
Why?
| | Choledochal Cyst | 1 | 1998 | 17 | 0.150 |
Why?
| | Cell Adhesion Molecules | 1 | 2019 | 168 | 0.150 |
Why?
| | Organ Specificity | 2 | 2013 | 268 | 0.150 |
Why?
| | Interferon-alpha | 2 | 2011 | 187 | 0.150 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 1998 | 15 | 0.150 |
Why?
| | Neurogenesis | 1 | 2019 | 102 | 0.150 |
Why?
| | Skin | 1 | 2022 | 659 | 0.150 |
Why?
| | Tissue Culture Techniques | 2 | 2021 | 66 | 0.150 |
Why?
| | Glioblastoma | 1 | 2000 | 253 | 0.150 |
Why?
| | Hybridomas | 2 | 1995 | 230 | 0.150 |
Why?
| | Neuromyelitis Optica | 1 | 2019 | 115 | 0.150 |
Why?
| | Brazil | 1 | 2017 | 90 | 0.150 |
Why?
| | Autoantibodies | 3 | 2021 | 1350 | 0.140 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2019 | 182 | 0.140 |
Why?
| | Dexamethasone | 2 | 2017 | 317 | 0.140 |
Why?
| | Cranial Nerve Diseases | 1 | 2017 | 42 | 0.140 |
Why?
| | Memory Disorders | 2 | 2016 | 154 | 0.140 |
Why?
| | Transcription Factors | 1 | 2005 | 1528 | 0.140 |
Why?
| | Movement Disorders | 1 | 2017 | 46 | 0.140 |
Why?
| | Brain Ischemia | 1 | 2020 | 299 | 0.140 |
Why?
| | Microfilament Proteins | 1 | 2017 | 127 | 0.140 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2017 | 135 | 0.140 |
Why?
| | Muscular Diseases | 1 | 2017 | 104 | 0.140 |
Why?
| | Protein Binding | 3 | 2016 | 1896 | 0.140 |
Why?
| | Ticks | 1 | 2016 | 12 | 0.130 |
Why?
| | Calcium-Binding Proteins | 1 | 2017 | 207 | 0.130 |
Why?
| | Encephalitis Viruses, Tick-Borne | 1 | 2016 | 7 | 0.130 |
Why?
| | Colorado | 5 | 2022 | 4086 | 0.130 |
Why?
| | Encephalopathy, Bovine Spongiform | 1 | 1995 | 2 | 0.130 |
Why?
| | Culicidae | 1 | 2016 | 29 | 0.130 |
Why?
| | Interferon-gamma | 1 | 2019 | 722 | 0.130 |
Why?
| | Presynaptic Terminals | 1 | 2016 | 55 | 0.130 |
Why?
| | Microcephaly | 1 | 2016 | 51 | 0.130 |
Why?
| | Protein Interaction Mapping | 1 | 2016 | 101 | 0.130 |
Why?
| | Biliary Atresia | 1 | 1998 | 183 | 0.130 |
Why?
| | DNA | 3 | 2017 | 1351 | 0.130 |
Why?
| | Cell Proliferation | 1 | 2023 | 2196 | 0.130 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 529 | 0.130 |
Why?
| | Arcuate Nucleus of Hypothalamus | 1 | 1995 | 13 | 0.130 |
Why?
| | Agricultural Workers' Diseases | 1 | 1995 | 23 | 0.130 |
Why?
| | Myocardium | 3 | 2005 | 908 | 0.130 |
Why?
| | Spleen | 4 | 2011 | 484 | 0.130 |
Why?
| | Muscle Hypotonia | 1 | 2015 | 31 | 0.120 |
Why?
| | Brain Stem | 1 | 1995 | 101 | 0.120 |
Why?
| | Chikungunya virus | 1 | 2016 | 61 | 0.120 |
Why?
| | Cell Count | 2 | 2005 | 305 | 0.120 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 797 | 0.120 |
Why?
| | Cricetinae | 3 | 2012 | 254 | 0.120 |
Why?
| | Nerve Fibers | 1 | 1995 | 87 | 0.120 |
Why?
| | Aged | 9 | 2019 | 19079 | 0.120 |
Why?
| | Medulla Oblongata | 1 | 1994 | 33 | 0.120 |
Why?
| | Cerebral Infarction | 1 | 1994 | 39 | 0.120 |
Why?
| | Demyelinating Diseases | 1 | 1995 | 75 | 0.120 |
Why?
| | Fingolimod Hydrochloride | 1 | 2015 | 29 | 0.120 |
Why?
| | Virus Cultivation | 1 | 2014 | 25 | 0.120 |
Why?
| | West Nile Virus Vaccines | 1 | 2014 | 1 | 0.120 |
Why?
| | Endopeptidases | 1 | 1994 | 71 | 0.120 |
Why?
| | Epilepsy | 1 | 1998 | 277 | 0.120 |
Why?
| | Neuronal Plasticity | 1 | 2016 | 209 | 0.120 |
Why?
| | Receptors, Interleukin-17 | 1 | 2014 | 5 | 0.120 |
Why?
| | Facial Nerve | 2 | 2007 | 31 | 0.120 |
Why?
| | Kidney | 2 | 2011 | 1184 | 0.120 |
Why?
| | Fibroblasts | 4 | 2007 | 838 | 0.120 |
Why?
| | Proto-Oncogene Proteins c-jun | 2 | 2005 | 47 | 0.120 |
Why?
| | rac GTP-Binding Proteins | 2 | 2012 | 34 | 0.120 |
Why?
| | Amino Acyl-tRNA Synthetases | 1 | 2014 | 28 | 0.110 |
Why?
| | Practice Guidelines as Topic | 3 | 2007 | 1393 | 0.110 |
Why?
| | Microarray Analysis | 1 | 2014 | 119 | 0.110 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2017 | 288 | 0.110 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 863 | 0.110 |
Why?
| | Treponema pallidum | 1 | 2013 | 7 | 0.110 |
Why?
| | RNA-Binding Proteins | 1 | 1996 | 344 | 0.110 |
Why?
| | Gene Expression Regulation, Viral | 2 | 2005 | 80 | 0.110 |
Why?
| | Bacterial Toxins | 2 | 2012 | 103 | 0.110 |
Why?
| | Biomarkers | 2 | 2017 | 3414 | 0.110 |
Why?
| | Complement System Proteins | 1 | 2016 | 285 | 0.110 |
Why?
| | Tachycardia | 1 | 2013 | 50 | 0.110 |
Why?
| | Immunotherapy, Adoptive | 2 | 1993 | 184 | 0.110 |
Why?
| | Rats | 7 | 2012 | 4943 | 0.110 |
Why?
| | Propidium | 1 | 2013 | 4 | 0.110 |
Why?
| | Hydro-Lyases | 1 | 2013 | 4 | 0.110 |
Why?
| | Myocytes, Cardiac | 2 | 2009 | 448 | 0.110 |
Why?
| | Cryoultramicrotomy | 1 | 2013 | 3 | 0.110 |
Why?
| | Buffers | 1 | 2013 | 53 | 0.110 |
Why?
| | Cerebrospinal Fluid Proteins | 2 | 2005 | 10 | 0.100 |
Why?
| | Leukocytosis | 2 | 2005 | 35 | 0.100 |
Why?
| | History, 18th Century | 2 | 2010 | 18 | 0.100 |
Why?
| | B-Lymphocytes | 2 | 2009 | 769 | 0.100 |
Why?
| | Phagosomes | 1 | 2012 | 38 | 0.100 |
Why?
| | Drug Design | 1 | 2013 | 151 | 0.100 |
Why?
| | Glutamic Acid | 1 | 2014 | 211 | 0.100 |
Why?
| | Etoposide | 2 | 2003 | 148 | 0.100 |
Why?
| | Cytoplasm | 1 | 2013 | 255 | 0.100 |
Why?
| | Genetic Techniques | 2 | 2011 | 58 | 0.100 |
Why?
| | STAT5 Transcription Factor | 1 | 2012 | 44 | 0.100 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 396 | 0.100 |
Why?
| | Fever | 1 | 2013 | 279 | 0.100 |
Why?
| | Myxovirus Resistance Proteins | 1 | 2011 | 8 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2005 | 1846 | 0.100 |
Why?
| | Cerebral Cortex | 2 | 2005 | 380 | 0.090 |
Why?
| | T-Lymphocytes | 3 | 1998 | 1745 | 0.090 |
Why?
| | Nitrendipine | 1 | 1991 | 13 | 0.090 |
Why?
| | Infant | 5 | 2022 | 7935 | 0.090 |
Why?
| | Cyclosporins | 1 | 1991 | 58 | 0.090 |
Why?
| | Verapamil | 1 | 1991 | 32 | 0.090 |
Why?
| | Histocytochemistry | 1 | 2011 | 79 | 0.090 |
Why?
| | Fatal Outcome | 3 | 2009 | 284 | 0.090 |
Why?
| | GTP-Binding Proteins | 1 | 2011 | 139 | 0.090 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2003 | 743 | 0.090 |
Why?
| | Caspases, Effector | 1 | 2010 | 2 | 0.090 |
Why?
| | Autophagy | 1 | 2012 | 233 | 0.090 |
Why?
| | Hippocampus | 2 | 2005 | 695 | 0.090 |
Why?
| | Medical Illustration | 1 | 2010 | 7 | 0.090 |
Why?
| | History, 17th Century | 1 | 2010 | 15 | 0.090 |
Why?
| | Glutamate Plasma Membrane Transport Proteins | 1 | 2009 | 5 | 0.090 |
Why?
| | Interferon Regulatory Factors | 1 | 2010 | 29 | 0.090 |
Why?
| | Virus Physiological Phenomena | 1 | 2009 | 6 | 0.090 |
Why?
| | Disease Vectors | 1 | 2009 | 11 | 0.090 |
Why?
| | Microscopy | 1 | 2011 | 125 | 0.080 |
Why?
| | Muscle, Skeletal | 2 | 2017 | 1472 | 0.080 |
Why?
| | Greenhouse Effect | 1 | 2009 | 6 | 0.080 |
Why?
| | RNA, Messenger | 2 | 2009 | 2557 | 0.080 |
Why?
| | Animals, Wild | 1 | 2009 | 44 | 0.080 |
Why?
| | United Kingdom | 2 | 2003 | 226 | 0.080 |
Why?
| | Bone Morphogenetic Protein Receptors, Type I | 1 | 2009 | 10 | 0.080 |
Why?
| | Microtubule-Associated Proteins | 2 | 2012 | 174 | 0.080 |
Why?
| | Smad1 Protein | 1 | 2009 | 18 | 0.080 |
Why?
| | Mutation | 4 | 2014 | 3349 | 0.080 |
Why?
| | Smad3 Protein | 1 | 2009 | 41 | 0.080 |
Why?
| | Kinetics | 3 | 2005 | 1550 | 0.080 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2009 | 12 | 0.080 |
Why?
| | DNA Primers | 2 | 2003 | 514 | 0.080 |
Why?
| | Virus Activation | 3 | 2003 | 78 | 0.080 |
Why?
| | Bacterial Proteins | 2 | 2012 | 739 | 0.080 |
Why?
| | Receptors, Virus | 2 | 2005 | 75 | 0.080 |
Why?
| | Reperfusion Injury | 1 | 1991 | 254 | 0.080 |
Why?
| | Nuclear Proteins | 1 | 2013 | 592 | 0.080 |
Why?
| | Epidural Space | 1 | 2008 | 6 | 0.080 |
Why?
| | Prognosis | 3 | 2019 | 3334 | 0.080 |
Why?
| | Adolescent | 6 | 2020 | 17808 | 0.080 |
Why?
| | Myokymia | 1 | 2007 | 2 | 0.070 |
Why?
| | Schizophrenia, Paranoid | 1 | 2007 | 9 | 0.070 |
Why?
| | Retrospective Studies | 6 | 2022 | 12513 | 0.070 |
Why?
| | Developing Countries | 1 | 2009 | 236 | 0.070 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2008 | 88 | 0.070 |
Why?
| | STAT2 Transcription Factor | 1 | 2007 | 3 | 0.070 |
Why?
| | Seizures | 2 | 2008 | 339 | 0.070 |
Why?
| | Cell Movement | 2 | 2003 | 867 | 0.070 |
Why?
| | Intervertebral Disc | 1 | 2008 | 35 | 0.070 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2007 | 48 | 0.070 |
Why?
| | Phosphorylation | 2 | 2012 | 1571 | 0.070 |
Why?
| | Morbidity | 1 | 2008 | 277 | 0.070 |
Why?
| | Vero Cells | 3 | 2012 | 63 | 0.070 |
Why?
| | Disease Reservoirs | 1 | 2007 | 18 | 0.070 |
Why?
| | Survival Rate | 1 | 2011 | 1642 | 0.070 |
Why?
| | Lung Transplantation | 1 | 2009 | 246 | 0.070 |
Why?
| | Herpesvirus Vaccines | 1 | 2007 | 4 | 0.070 |
Why?
| | Global Health | 1 | 2009 | 288 | 0.070 |
Why?
| | Herpesviridae | 1 | 2007 | 21 | 0.070 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 271 | 0.070 |
Why?
| | Risk | 1 | 2009 | 815 | 0.070 |
Why?
| | Hemagglutinins, Viral | 1 | 1986 | 6 | 0.070 |
Why?
| | Hepatovirus | 1 | 1986 | 3 | 0.070 |
Why?
| | Disease Transmission, Infectious | 1 | 2007 | 56 | 0.070 |
Why?
| | Meningitis, Aseptic | 2 | 2003 | 15 | 0.070 |
Why?
| | Transfusion Reaction | 1 | 2007 | 65 | 0.070 |
Why?
| | Mice, Inbred Strains | 4 | 1993 | 396 | 0.070 |
Why?
| | Virus Latency | 1 | 2007 | 80 | 0.070 |
Why?
| | Risk Factors | 4 | 2009 | 8626 | 0.070 |
Why?
| | Mice, Inbred C57BL | 4 | 2013 | 4710 | 0.070 |
Why?
| | Cell Division | 2 | 2000 | 759 | 0.070 |
Why?
| | S-Nitroso-N-Acetylpenicillamine | 1 | 2005 | 4 | 0.060 |
Why?
| | Serologic Tests | 1 | 2005 | 49 | 0.060 |
Why?
| | Glutathione | 1 | 2007 | 300 | 0.060 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2005 | 38 | 0.060 |
Why?
| | Osmolar Concentration | 1 | 2005 | 173 | 0.060 |
Why?
| | Interferon beta-1a | 1 | 2005 | 12 | 0.060 |
Why?
| | Promoter Regions, Genetic | 1 | 2010 | 1133 | 0.060 |
Why?
| | Aged, 80 and over | 2 | 2007 | 6346 | 0.060 |
Why?
| | Analgesics | 1 | 2007 | 158 | 0.060 |
Why?
| | Orthoreovirus, Avian | 1 | 2005 | 1 | 0.060 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2005 | 56 | 0.060 |
Why?
| | Administration, Oral | 2 | 2004 | 731 | 0.060 |
Why?
| | England | 2 | 2000 | 65 | 0.060 |
Why?
| | Predictive Value of Tests | 2 | 2009 | 1795 | 0.060 |
Why?
| | Saimiri | 1 | 2004 | 6 | 0.060 |
Why?
| | Neurophysiology | 1 | 1984 | 13 | 0.060 |
Why?
| | Drug Therapy, Combination | 1 | 2007 | 954 | 0.060 |
Why?
| | Pregnancy | 1 | 2016 | 5525 | 0.060 |
Why?
| | Digestive System | 1 | 2004 | 27 | 0.060 |
Why?
| | Ultraviolet Rays | 2 | 1999 | 366 | 0.060 |
Why?
| | Nuclear Lamina | 1 | 2004 | 10 | 0.060 |
Why?
| | Nuclear Pore | 1 | 2004 | 14 | 0.060 |
Why?
| | Nuclear Localization Signals | 1 | 2004 | 14 | 0.060 |
Why?
| | Serotyping | 1 | 2004 | 28 | 0.060 |
Why?
| | Clinical Trials as Topic | 1 | 2009 | 934 | 0.060 |
Why?
| | Pancreas Transplantation | 1 | 2004 | 61 | 0.060 |
Why?
| | Down-Regulation | 1 | 2007 | 596 | 0.060 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 2004 | 22 | 0.060 |
Why?
| | Thalamus | 1 | 2005 | 74 | 0.060 |
Why?
| | Random Allocation | 1 | 2005 | 335 | 0.060 |
Why?
| | Retinal Ganglion Cells | 1 | 1985 | 92 | 0.060 |
Why?
| | Inflammation Mediators | 2 | 2021 | 476 | 0.060 |
Why?
| | Inclusion Bodies, Viral | 1 | 2003 | 2 | 0.060 |
Why?
| | Glycoproteins | 1 | 2005 | 304 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2017 | 4420 | 0.060 |
Why?
| | AIDS-Related Opportunistic Infections | 2 | 2009 | 116 | 0.060 |
Why?
| | Vinculin | 1 | 2003 | 10 | 0.060 |
Why?
| | Enterovirus B, Human | 1 | 2023 | 24 | 0.060 |
Why?
| | Liver | 1 | 2011 | 1631 | 0.050 |
Why?
| | Reflex, Stretch | 1 | 1983 | 9 | 0.050 |
Why?
| | Diagnostic Techniques, Ophthalmological | 1 | 2003 | 36 | 0.050 |
Why?
| | Adrenal Cortex Hormones | 1 | 2007 | 498 | 0.050 |
Why?
| | Skin Diseases, Vesiculobullous | 1 | 2003 | 17 | 0.050 |
Why?
| | Herpesvirus 2, Human | 1 | 2003 | 27 | 0.050 |
Why?
| | Hepatolenticular Degeneration | 1 | 1983 | 16 | 0.050 |
Why?
| | Chorea | 1 | 1983 | 11 | 0.050 |
Why?
| | Infusions, Intravenous | 1 | 2004 | 372 | 0.050 |
Why?
| | Isoxazoles | 1 | 2023 | 52 | 0.050 |
Why?
| | Diagnosis, Differential | 3 | 2017 | 1340 | 0.050 |
Why?
| | Mice, Inbred BALB C | 2 | 1998 | 1151 | 0.050 |
Why?
| | District of Columbia | 1 | 2022 | 24 | 0.050 |
Why?
| | Luciferases | 1 | 2003 | 142 | 0.050 |
Why?
| | Muscular Dystrophies | 1 | 1983 | 36 | 0.050 |
Why?
| | Tumor Virus Infections | 1 | 2002 | 43 | 0.050 |
Why?
| | Retina | 1 | 1985 | 263 | 0.050 |
Why?
| | Cryoelectron Microscopy | 1 | 2023 | 144 | 0.050 |
Why?
| | Tissue Distribution | 1 | 2003 | 285 | 0.050 |
Why?
| | Genes, Reporter | 1 | 2003 | 257 | 0.050 |
Why?
| | Ribavirin | 1 | 2003 | 89 | 0.050 |
Why?
| | Models, Biological | 2 | 2003 | 1630 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2004 | 354 | 0.050 |
Why?
| | AIDS Dementia Complex | 1 | 2002 | 50 | 0.050 |
Why?
| | Multivariate Analysis | 1 | 2005 | 1435 | 0.050 |
Why?
| | Transfection | 1 | 2004 | 870 | 0.050 |
Why?
| | Proto-Oncogene Proteins | 1 | 2005 | 610 | 0.050 |
Why?
| | I-kappa B Proteins | 1 | 2002 | 78 | 0.050 |
Why?
| | Electromyography | 2 | 2017 | 326 | 0.050 |
Why?
| | Body Fluids | 1 | 2001 | 58 | 0.050 |
Why?
| | Endoplasmic Reticulum | 1 | 2003 | 234 | 0.050 |
Why?
| | Radiography | 1 | 2004 | 811 | 0.050 |
Why?
| | Patients | 1 | 2002 | 162 | 0.050 |
Why?
| | Phenotype | 1 | 2009 | 2811 | 0.050 |
Why?
| | Pain | 1 | 2007 | 710 | 0.050 |
Why?
| | Amino Acid Sequence | 2 | 2004 | 1988 | 0.050 |
Why?
| | Ligands | 1 | 2003 | 564 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2017 | 3004 | 0.050 |
Why?
| | Creatine Kinase | 1 | 2001 | 75 | 0.050 |
Why?
| | Fas-Associated Death Domain Protein | 1 | 2000 | 8 | 0.050 |
Why?
| | Haplorhini | 1 | 2000 | 57 | 0.050 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2000 | 26 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 4 | 2009 | 2209 | 0.040 |
Why?
| | Species Specificity | 2 | 1995 | 545 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2005 | 824 | 0.040 |
Why?
| | False Positive Reactions | 1 | 2000 | 108 | 0.040 |
Why?
| | Knee Joint | 1 | 1983 | 323 | 0.040 |
Why?
| | Cell Line, Tumor | 1 | 2007 | 2725 | 0.040 |
Why?
| | Population Surveillance | 1 | 2003 | 392 | 0.040 |
Why?
| | Recurrence | 3 | 1995 | 936 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2020 | 124 | 0.040 |
Why?
| | Bunyamwera virus | 1 | 2019 | 3 | 0.040 |
Why?
| | Multiplex Polymerase Chain Reaction | 1 | 2020 | 45 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2005 | 1022 | 0.040 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2020 | 92 | 0.040 |
Why?
| | Gerstmann-Straussler-Scheinker Disease | 1 | 1999 | 1 | 0.040 |
Why?
| | Creosote | 1 | 1999 | 2 | 0.040 |
Why?
| | Cross-Sectional Studies | 1 | 2009 | 4406 | 0.040 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2004 | 524 | 0.040 |
Why?
| | Antidiarrheals | 1 | 1999 | 15 | 0.040 |
Why?
| | Muscle Weakness | 1 | 1999 | 80 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 546 | 0.040 |
Why?
| | Jejunum | 1 | 1999 | 24 | 0.040 |
Why?
| | Acrylates | 1 | 1999 | 45 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2000 | 278 | 0.040 |
Why?
| | Virus Attachment | 1 | 2018 | 11 | 0.040 |
Why?
| | A549 Cells | 1 | 2018 | 51 | 0.040 |
Why?
| | Age Factors | 1 | 2005 | 2889 | 0.040 |
Why?
| | Kidney Transplantation | 1 | 2004 | 541 | 0.040 |
Why?
| | Epitopes | 2 | 1991 | 435 | 0.040 |
Why?
| | Neural Pathways | 1 | 1999 | 258 | 0.040 |
Why?
| | Antimicrobial Stewardship | 1 | 2020 | 94 | 0.040 |
Why?
| | Arboviruses | 1 | 2017 | 10 | 0.040 |
Why?
| | Vasculitis | 1 | 1998 | 70 | 0.040 |
Why?
| | In Vitro Techniques | 2 | 1999 | 1013 | 0.040 |
Why?
| | Liver Transplantation | 1 | 2004 | 706 | 0.040 |
Why?
| | Neural Conduction | 1 | 2017 | 78 | 0.040 |
Why?
| | Plant Extracts | 1 | 1999 | 155 | 0.040 |
Why?
| | Brain Mapping | 1 | 2000 | 522 | 0.030 |
Why?
| | Colon | 1 | 1999 | 233 | 0.030 |
Why?
| | Atrophy | 1 | 2017 | 151 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2020 | 479 | 0.030 |
Why?
| | Metagenomics | 1 | 2017 | 131 | 0.030 |
Why?
| | CA3 Region, Hippocampal | 1 | 2016 | 5 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2002 | 1147 | 0.030 |
Why?
| | Complement Pathway, Classical | 1 | 2016 | 19 | 0.030 |
Why?
| | Spatial Memory | 1 | 2016 | 17 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 343 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2000 | 1690 | 0.030 |
Why?
| | Immunity, Cellular | 1 | 1998 | 248 | 0.030 |
Why?
| | Proteins | 1 | 2002 | 912 | 0.030 |
Why?
| | Meat Products | 1 | 1995 | 25 | 0.030 |
Why?
| | Blotting, Southern | 1 | 1995 | 68 | 0.030 |
Why?
| | Young Adult | 2 | 2022 | 10462 | 0.030 |
Why?
| | Food Handling | 1 | 1995 | 49 | 0.030 |
Why?
| | Phenylketonurias | 1 | 1995 | 12 | 0.030 |
Why?
| | Microscopy, Electron | 1 | 1995 | 410 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2017 | 250 | 0.030 |
Why?
| | Ammonium Chloride | 1 | 1994 | 4 | 0.030 |
Why?
| | Chymotrypsin | 1 | 1994 | 16 | 0.030 |
Why?
| | Cognition Disorders | 2 | 2009 | 476 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2019 | 681 | 0.030 |
Why?
| | Necrosis | 2 | 1998 | 210 | 0.030 |
Why?
| | Complement Activation | 1 | 2016 | 340 | 0.030 |
Why?
| | Neuropsychological Tests | 2 | 2008 | 913 | 0.030 |
Why?
| | Base Sequence | 2 | 1995 | 2118 | 0.030 |
Why?
| | Cell Survival | 2 | 2005 | 1021 | 0.030 |
Why?
| | Antibody Affinity | 1 | 1993 | 52 | 0.030 |
Why?
| | DNA Damage | 1 | 1995 | 357 | 0.030 |
Why?
| | Co-Repressor Proteins | 1 | 2013 | 13 | 0.030 |
Why?
| | Cattle | 1 | 1995 | 921 | 0.030 |
Why?
| | Thymidine Kinase | 2 | 1989 | 14 | 0.030 |
Why?
| | Syndrome | 2 | 2007 | 334 | 0.030 |
Why?
| | Occupational Exposure | 1 | 1995 | 255 | 0.030 |
Why?
| | Anti-HIV Agents | 1 | 1999 | 666 | 0.030 |
Why?
| | Trigeminal Ganglion | 2 | 1989 | 21 | 0.030 |
Why?
| | bcl-X Protein | 1 | 2012 | 38 | 0.020 |
Why?
| | Cohort Studies | 1 | 2022 | 4899 | 0.020 |
Why?
| | Hemagglutination | 1 | 1991 | 7 | 0.020 |
Why?
| | Triterpenes | 1 | 2012 | 17 | 0.020 |
Why?
| | Binding Sites, Antibody | 1 | 1991 | 36 | 0.020 |
Why?
| | Immunoglobulin Isotypes | 1 | 1991 | 32 | 0.020 |
Why?
| | Proteolysis | 1 | 2012 | 143 | 0.020 |
Why?
| | Primary Cell Culture | 1 | 2012 | 149 | 0.020 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 1 | 1991 | 84 | 0.020 |
Why?
| | Molecular Chaperones | 1 | 2013 | 157 | 0.020 |
Why?
| | CD8 Antigens | 1 | 1991 | 69 | 0.020 |
Why?
| | Clone Cells | 1 | 1991 | 248 | 0.020 |
Why?
| | CD4 Antigens | 1 | 1991 | 124 | 0.020 |
Why?
| | Diuresis | 1 | 1991 | 8 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 1998 | 2762 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 1991 | 354 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 1991 | 489 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2012 | 330 | 0.020 |
Why?
| | STAT3 Transcription Factor | 1 | 2012 | 173 | 0.020 |
Why?
| | Antibody Formation | 1 | 1991 | 267 | 0.020 |
Why?
| | Calcium Channels | 1 | 1991 | 145 | 0.020 |
Why?
| | Nerve Fibers, Unmyelinated | 1 | 2009 | 9 | 0.020 |
Why?
| | Excitatory Amino Acid Transporter 2 | 1 | 2009 | 13 | 0.020 |
Why?
| | Prospective Studies | 2 | 1998 | 6216 | 0.020 |
Why?
| | Incidence | 1 | 1995 | 2312 | 0.020 |
Why?
| | CD11 Antigens | 1 | 2009 | 30 | 0.020 |
Why?
| | Trigeminal Nerve | 1 | 1989 | 28 | 0.020 |
Why?
| | Esophagitis | 1 | 1989 | 65 | 0.020 |
Why?
| | Paresis | 1 | 2009 | 28 | 0.020 |
Why?
| | Immunoglobulins | 1 | 2009 | 143 | 0.020 |
Why?
| | Precipitin Tests | 1 | 1988 | 88 | 0.020 |
Why?
| | Hemagglutination Inhibition Tests | 1 | 1988 | 37 | 0.020 |
Why?
| | Optic Neuritis | 1 | 2009 | 37 | 0.020 |
Why?
| | Dendrites | 1 | 2009 | 85 | 0.020 |
Why?
| | Radioimmunoassay | 1 | 1988 | 163 | 0.020 |
Why?
| | alpha 1-Antitrypsin Deficiency | 1 | 2009 | 69 | 0.020 |
Why?
| | Cross Reactions | 1 | 1988 | 117 | 0.020 |
Why?
| | Muscles | 1 | 1989 | 320 | 0.020 |
Why?
| | Genetic Variation | 1 | 1993 | 876 | 0.020 |
Why?
| | Mental Status Schedule | 1 | 2008 | 33 | 0.020 |
Why?
| | Isaacs Syndrome | 1 | 2007 | 4 | 0.020 |
Why?
| | Skin Diseases | 1 | 2009 | 122 | 0.020 |
Why?
| | Glomerular Filtration Rate | 1 | 1991 | 604 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 1991 | 1044 | 0.020 |
Why?
| | Neurologic Examination | 1 | 2008 | 114 | 0.020 |
Why?
| | Gene Expression | 1 | 2012 | 1420 | 0.020 |
Why?
| | Peripheral Nerves | 1 | 2007 | 64 | 0.020 |
Why?
| | Oxidants | 1 | 2007 | 112 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 1998 | 4622 | 0.020 |
Why?
| | Protein Kinase Inhibitors | 1 | 2012 | 795 | 0.020 |
Why?
| | Prednisone | 1 | 2007 | 231 | 0.020 |
Why?
| | Genes, Regulator | 1 | 1986 | 34 | 0.020 |
Why?
| | Forelimb | 1 | 1986 | 24 | 0.020 |
Why?
| | Superoxides | 1 | 2007 | 214 | 0.020 |
Why?
| | RNA, Double-Stranded | 1 | 1986 | 44 | 0.020 |
Why?
| | Synapses | 1 | 2009 | 330 | 0.020 |
Why?
| | Sciatic Nerve | 1 | 1986 | 56 | 0.020 |
Why?
| | Graft Rejection | 1 | 2009 | 516 | 0.020 |
Why?
| | Hindlimb | 1 | 1986 | 130 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2016 | 5035 | 0.020 |
Why?
| | Bcl-2-Like Protein 11 | 1 | 2005 | 37 | 0.020 |
Why?
| | Genes, Dominant | 1 | 2005 | 94 | 0.020 |
Why?
| | Politics | 1 | 1986 | 79 | 0.020 |
Why?
| | rho GTP-Binding Proteins | 1 | 2005 | 61 | 0.020 |
Why?
| | Integrins | 1 | 2005 | 79 | 0.020 |
Why?
| | Blood Pressure | 1 | 1991 | 1530 | 0.010 |
Why?
| | Pathology | 1 | 1984 | 20 | 0.010 |
Why?
| | Vesicular stomatitis Indiana virus | 1 | 2004 | 13 | 0.010 |
Why?
| | Muromegalovirus | 1 | 2004 | 13 | 0.010 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 2004 | 20 | 0.010 |
Why?
| | Massachusetts | 1 | 1984 | 134 | 0.010 |
Why?
| | Cell Adhesion | 1 | 2005 | 430 | 0.010 |
Why?
| | Immunotherapy | 1 | 2007 | 475 | 0.010 |
Why?
| | Antioxidants | 1 | 2007 | 530 | 0.010 |
Why?
| | Aphasia | 1 | 2003 | 19 | 0.010 |
Why?
| | Schools, Medical | 1 | 1984 | 120 | 0.010 |
Why?
| | Focal Adhesion Kinase 1 | 1 | 2003 | 27 | 0.010 |
Why?
| | Focal Adhesion Protein-Tyrosine Kinases | 1 | 2003 | 27 | 0.010 |
Why?
| | Temporal Lobe | 1 | 2003 | 79 | 0.010 |
Why?
| | Toll-Like Receptors | 1 | 2004 | 166 | 0.010 |
Why?
| | Patella | 1 | 1983 | 22 | 0.010 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2003 | 83 | 0.010 |
Why?
| | Intestines | 1 | 1986 | 325 | 0.010 |
Why?
| | Lethal Dose 50 | 1 | 2002 | 12 | 0.010 |
Why?
| | Hydrolysis | 1 | 2003 | 175 | 0.010 |
Why?
| | Fluorescence | 1 | 2003 | 148 | 0.010 |
Why?
| | Epidermal Growth Factor | 1 | 2003 | 162 | 0.010 |
Why?
| | Papillomaviridae | 1 | 2003 | 102 | 0.010 |
Why?
| | Hypertrophy | 1 | 1983 | 109 | 0.010 |
Why?
| | Injections, Intramuscular | 1 | 2002 | 117 | 0.010 |
Why?
| | Headache | 1 | 2003 | 132 | 0.010 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 2002 | 52 | 0.010 |
Why?
| | DNA Fingerprinting | 1 | 2002 | 27 | 0.010 |
Why?
| | Electroencephalography | 1 | 2003 | 362 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2007 | 1084 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 928 | 0.010 |
Why?
| | Liver Diseases | 1 | 2003 | 254 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2002 | 524 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2002 | 854 | 0.010 |
Why?
| | Cysteine Endopeptidases | 1 | 2000 | 60 | 0.010 |
Why?
| | Multienzyme Complexes | 1 | 2000 | 64 | 0.010 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2003 | 398 | 0.010 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2000 | 134 | 0.010 |
Why?
| | Drug Resistance, Microbial | 2 | 1989 | 67 | 0.010 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2004 | 689 | 0.010 |
Why?
| | Ion Transport | 1 | 1999 | 55 | 0.010 |
Why?
| | Gene Deletion | 1 | 2000 | 356 | 0.010 |
Why?
| | Kidney Failure, Chronic | 1 | 2003 | 487 | 0.010 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2004 | 965 | 0.010 |
Why?
| | HIV Seropositivity | 1 | 1998 | 109 | 0.010 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2002 | 584 | 0.010 |
Why?
| | Diet, Protein-Restricted | 1 | 1995 | 10 | 0.010 |
Why?
| | Phenylalanine | 1 | 1995 | 57 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2002 | 1314 | 0.010 |
Why?
| | Immunoblotting | 1 | 1994 | 283 | 0.010 |
Why?
| | Lymphocyte Depletion | 1 | 1993 | 116 | 0.010 |
Why?
| | Lymphocytes | 1 | 1994 | 332 | 0.010 |
Why?
| | Amino Acids | 1 | 1995 | 448 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 2002 | 1868 | 0.010 |
Why?
| | Viral Plaque Assay | 1 | 1989 | 24 | 0.010 |
Why?
| | Restriction Mapping | 1 | 1989 | 77 | 0.010 |
Why?
| | Lung Neoplasms | 1 | 2002 | 2199 | 0.010 |
Why?
| | Chromosome Deletion | 1 | 1989 | 95 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 1989 | 187 | 0.010 |
Why?
| | Genes | 1 | 1989 | 224 | 0.000 |
Why?
| | Eye | 1 | 1989 | 101 | 0.000 |
Why?
| | Codon | 1 | 1986 | 86 | 0.000 |
Why?
|
|
Tyler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|